These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 25190457)

  • 21. Quantitative analysis of the transcription control mechanism.
    Mao C; Brown CR; Falkovskaia E; Dong S; Hrabeta-Robinson E; Wenger L; Boeger H
    Mol Syst Biol; 2010 Nov; 6():431. PubMed ID: 21081924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The chromatin remodelers RSC and ISW1 display functional and chromatin-based promoter antagonism.
    Parnell TJ; Schlichter A; Wilson BG; Cairns BR
    Elife; 2015 Mar; 4():e06073. PubMed ID: 25821983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for histone eviction in trans upon induction of the yeast PHO5 promoter.
    Korber P; Luckenbach T; Blaschke D; Hörz W
    Mol Cell Biol; 2004 Dec; 24(24):10965-74. PubMed ID: 15572697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Active PHO5 chromatin encompasses variable numbers of nucleosomes at individual promoters.
    Jessen WJ; Hoose SA; Kilgore JA; Kladde MP
    Nat Struct Mol Biol; 2006 Mar; 13(3):256-63. PubMed ID: 16491089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective removal of promoter nucleosomes by the RSC chromatin-remodeling complex.
    Lorch Y; Griesenbeck J; Boeger H; Maier-Davis B; Kornberg RD
    Nat Struct Mol Biol; 2011 Jul; 18(8):881-5. PubMed ID: 21725295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Promoter occupancy is a major determinant of chromatin remodeling enzyme requirements.
    Dhasarathy A; Kladde MP
    Mol Cell Biol; 2005 Apr; 25(7):2698-707. PubMed ID: 15767675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single-cell nucleosome mapping reveals the molecular basis of gene expression heterogeneity.
    Small EC; Xi L; Wang JP; Widom J; Licht JD
    Proc Natl Acad Sci U S A; 2014 Jun; 111(24):E2462-71. PubMed ID: 24889621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antisense non-coding transcription represses the PHO5 model gene at the level of promoter chromatin structure.
    Novačić A; Menéndez D; Ljubas J; Barbarić S; Stutz F; Soudet J; Stuparević I
    PLoS Genet; 2022 Oct; 18(10):e1010432. PubMed ID: 36215302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histone H3 lysine 4 hypermethylation prevents aberrant nucleosome remodeling at the PHO5 promoter.
    Wang SS; Zhou BO; Zhou JQ
    Mol Cell Biol; 2011 Aug; 31(15):3171-81. PubMed ID: 21646424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A compendium of nucleosome and transcript profiles reveals determinants of chromatin architecture and transcription.
    van Bakel H; Tsui K; Gebbia M; Mnaimneh S; Hughes TR; Nislow C
    PLoS Genet; 2013 May; 9(5):e1003479. PubMed ID: 23658529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcriptional activators are dispensable for transcription in the absence of Spt6-mediated chromatin reassembly of promoter regions.
    Adkins MW; Tyler JK
    Mol Cell; 2006 Feb; 21(3):405-16. PubMed ID: 16455495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural and functional requirements for the chromatin transition at the PHO5 promoter in Saccharomyces cerevisiae upon PHO5 activation.
    Fascher KD; Schmitz J; Hörz W
    J Mol Biol; 1993 Jun; 231(3):658-67. PubMed ID: 8515443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mediator, TATA-binding protein, and RNA polymerase II contribute to low histone occupancy at active gene promoters in yeast.
    Ansari SA; Paul E; Sommer S; Lieleg C; He Q; Daly AZ; Rode KA; Barber WT; Ellis LC; LaPorta E; Orzechowski AM; Taylor E; Reeb T; Wong J; Korber P; Morse RH
    J Biol Chem; 2014 May; 289(21):14981-95. PubMed ID: 24727477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A role for noncoding transcription in activation of the yeast PHO5 gene.
    Uhler JP; Hertel C; Svejstrup JQ
    Proc Natl Acad Sci U S A; 2007 May; 104(19):8011-6. PubMed ID: 17470801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppression of inositol pyrophosphate toxicosis and hyper-repression of the fission yeast
    Schwer B; Innokentev A; Sanchez AM; Garg A; Shuman S
    mBio; 2024 Jul; 15(7):e0125224. PubMed ID: 38899862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Removal of positioned nucleosomes from the yeast PHO5 promoter upon PHO5 induction releases additional upstream activating DNA elements.
    Almer A; Rudolph H; Hinnen A; Hörz W
    EMBO J; 1986 Oct; 5(10):2689-96. PubMed ID: 3536481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contrasting roles of the RSC and ISW1/CHD1 chromatin remodelers in RNA polymerase II elongation and termination.
    Ocampo J; Chereji RV; Eriksson PR; Clark DJ
    Genome Res; 2019 Mar; 29(3):407-417. PubMed ID: 30683752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of transcription factor-mediated nucleosome disassembly in PHO5 gene expression.
    Kharerin H; Bhat PJ; Marko JF; Padinhateeri R
    Sci Rep; 2016 Feb; 6():20319. PubMed ID: 26843321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nucleosome disruption at the yeast PHO5 promoter upon PHO5 induction occurs in the absence of DNA replication.
    Schmid A; Fascher KD; Hörz W
    Cell; 1992 Nov; 71(5):853-64. PubMed ID: 1423633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FACT and the proteasome promote promoter chromatin disassembly and transcriptional initiation.
    Ransom M; Williams SK; Dechassa ML; Das C; Linger J; Adkins M; Liu C; Bartholomew B; Tyler JK
    J Biol Chem; 2009 Aug; 284(35):23461-71. PubMed ID: 19574230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.